You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

CLINICAL TRIALS PROFILE FOR HUMALOG KWIKPEN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for HUMALOG KWIKPEN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02971228 ↗ Feasibility Trial Testing the Bionic Pancreas With ZP4207 Completed Beta Bionics, Inc. Phase 2 2016-11-01 The purpose of this study was to determine whether the Bionic Pancreas with ZP4207 (dasiglucagon*) was feasible to improve glycemic control in adults with type 1 diabetes mellitus. *dasiglucagon is the proposed International Nonproprietary Name (pINN) for ZP4207
NCT02971228 ↗ Feasibility Trial Testing the Bionic Pancreas With ZP4207 Completed Massachusetts General Hospital Phase 2 2016-11-01 The purpose of this study was to determine whether the Bionic Pancreas with ZP4207 (dasiglucagon*) was feasible to improve glycemic control in adults with type 1 diabetes mellitus. *dasiglucagon is the proposed International Nonproprietary Name (pINN) for ZP4207
NCT02971228 ↗ Feasibility Trial Testing the Bionic Pancreas With ZP4207 Completed Zealand Pharma Phase 2 2016-11-01 The purpose of this study was to determine whether the Bionic Pancreas with ZP4207 (dasiglucagon*) was feasible to improve glycemic control in adults with type 1 diabetes mellitus. *dasiglucagon is the proposed International Nonproprietary Name (pINN) for ZP4207
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for HUMALOG KWIKPEN

Condition Name

Condition Name for HUMALOG KWIKPEN
Intervention Trials
Diabetes Mellitus, Type 1 1
Type 1 Diabetes Mellitus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for HUMALOG KWIKPEN
Intervention Trials
Diabetes Mellitus, Type 1 2
Diabetes Mellitus 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for HUMALOG KWIKPEN

Trials by Country

Trials by Country for HUMALOG KWIKPEN
Location Trials
Spain 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for HUMALOG KWIKPEN
Location Trials
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for HUMALOG KWIKPEN

Clinical Trial Phase

Clinical Trial Phase for HUMALOG KWIKPEN
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for HUMALOG KWIKPEN
Clinical Trial Phase Trials
Completed 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for HUMALOG KWIKPEN

Sponsor Name

Sponsor Name for HUMALOG KWIKPEN
Sponsor Trials
Zealand Pharma 1
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 1
Beta Bionics, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for HUMALOG KWIKPEN
Sponsor Trials
Other 2
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.